Publication:
Evaluation the cognitive functions in parkinson's disease patients with neuropsychometric tests and to identify its clinical correlates

dc.contributor.buuauthorYıldız, Demet
dc.contributor.buuauthorErer, Sevda Özbek
dc.contributor.buuauthorZarifoğlu, Mehmet
dc.contributor.buuauthorBakar, Mustafa
dc.contributor.buuauthorKarlı, Necdet
dc.contributor.buuauthorTürkeş, Nevin
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNöroloji Ana Bilim Dalı
dc.contributor.scopusid56496635100
dc.contributor.scopusid25635370800
dc.contributor.scopusid6603411305
dc.contributor.scopusid26643051200
dc.contributor.scopusid6506587942
dc.contributor.scopusid35886020700
dc.date.accessioned2022-09-14T07:19:42Z
dc.date.available2022-09-14T07:19:42Z
dc.date.issued2010
dc.description.abstractObjective: In this study, we aimed to evaluate the cognitive functions in Parkinson's disease patients with using neuropsychological assessment and to identify its clinical correlates in Parkinson's disease. Methods: Thirty-three patients with idiopatic Parkinson's disease (PD) and 16 control subjects who are being followed by the Neurology Outpatient Clinic were included in this study. After evaluation of the cognitive functions by using MMSE (Mini-Mental State Examination) test, all cases with PD were divided into 2 groups: normal and mild dementia. Glucose, hemoglobin, TSH, cholesterol, homocysteine, vitamin B12 and folic acid levels were examined. Depression was excluded using geriatric depression test. Results: Memory, attention, verbal and visual fluency were evaluated with neuropsychological tests. Both Parkinson's groups demonstrated poor performance compared to the control group, but mental fluency, planning, verbal-visual memory, results of Trail Making Test A and counting backwards were worse in the mild dementia group. Significant difference was found between control and mild dementia groups by orientation, mental control, abstract thinking, logical memory and visuospatial tests. According to Luria's drawing test, mental fluency, and stroop, planning and RAVEN tests, poor performance was observed in the mild dementia group when compared with the other two groups. Conclusion: MMSE test may be used to diagnose dementia in PD patients because of the correlation of MMSE scores and the other memory tests. However, due to disorders detected in verbal-visual memory, mental fluency and planning tests in patients with MMSE scores above 23, the importance of neuropsychological tests is emphasized in determining subclinical cognitive dysfunction in PD patients.
dc.description.abstractÇalışmada, Parkinson hastalarında kognitif fonksiyonları nöropsikolojik testlerle değerlendirerek Parkinson kliniği ile korelasyonun gösterilmesi amaçlandı. Yöntemler: Bu çalışmaya Uludağ Üniversitesi Tıp Fakültesi Nöroloji Anabilim Dalı Hareket Bozuklukları Polikliniği’nde izlenen idiopatik Parkinson hastalığı tanılı 33 hasta ve 16 sağlıklı kontrol grubu alındı. Olguların kognitif fonksiyonları MMSE (Mini-Mental State Examination- Minimental test) ile değerlendirilerek; Parkinson hastaları kognitif fonksiyonları normal olan ve hafif demansı olan hastalar şeklinde 2 gruba ayrıldı ve glukoz, hemoglobin, TSH, kolesterol, homosistein, B12 vitamini, folik asit değerleri incelendi. Geriatrik depresyon testi ile depresyon dışlandı.Bulgular: Parkinson hastaları ve kontrol grupları arasında nöropsikolojik testler ile bellek, dikkat, kelime ve şekil akıcılığı değerlendirilmiştir. Düşünce akışı, planlama, sözel-görsel bellek, Trail A ve geri sayı tekrarı testlerinde, hafif demansı olan Parkinson grubunda daha belirgin olmak üzere, her iki Parkinson grubunun kötü performans gösterdiği saptanmıştır. Oryantasyon, mental kontrol, soyut düşünme, mantıksal bellek ve vizyospasyal testlerde kontrol grubu ile hafif demansı olan Parkinson grubu arasında anlamlı fark saptandı. Luria çizim testi, Stroop, düşünce akışı, planlama, RAVEN testinde hafif demansı olan Parkinson grubunda diğer iki gruba göre kötü performans görüldü.Sonuç: MMSE skorlariyla bellek testlerinin korelasyon göstermesi nedeniyle Parkinson hastalarında demans tanısında MMSE testinin kullanılabileceğini; ancak MMSE skoru 23 ve üzeri olan Parkinson hastalarında sözel-görsel bellek, düşünce akışı ve planlama testlerinde bozuklukların saptanması, PH’da subklinik gelişen kognitif bozukluğun tanımlanmasında nöropsikolojik testlerin önemini göstermiştir.
dc.identifier.citationYıldız, D. vd. (2010). "Evaluation the cognitive functions in parkinson's disease patients with neuropsychometric tests and to identify its clinical correlates". Noropsikiyatri Arsivi, 47(1), 47-52.
dc.identifier.endpage52
dc.identifier.issn1300-0667
dc.identifier.issn1309-4866
dc.identifier.issue1
dc.identifier.scopus2-s2.0-77950376842
dc.identifier.startpage47
dc.identifier.urihttp://hdl.handle.net/11452/28700
dc.identifier.volume47
dc.identifier.wos000276106800008
dc.indexed.scopusScopus
dc.indexed.trdizinTrDizin
dc.indexed.wosSCIE
dc.language.isotr
dc.publisherTürk Nöropsikiyatri Derneği
dc.relation.journalNoropsikiyatri Arsivi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectParkinson's disease
dc.subjectMild dementia
dc.subjectNeuropsychological test
dc.subjectMini-mental-state
dc.subjectAlzheimers-disease
dc.subjectNeuropsychological prediction
dc.subjectDementia
dc.subjectImpairment
dc.subjectMemory
dc.subjectRisk
dc.subjectPerformance
dc.subjectAbility
dc.subjectNeurosciences & neurology
dc.subjectParkinson hastalığı
dc.subjectHafif demans
dc.subjectNöropsikolojik testler
dc.subject.emtreeCyanocobalamin
dc.subject.emtreeFolic acid
dc.subject.emtreeGlucose
dc.subject.emtreeHemoglobin
dc.subject.emtreeHomocysteine
dc.subject.emtreeHhyrotropin
dc.subject.emtreeArticle
dc.subject.emtreeAttention
dc.subject.emtreeBrain function
dc.subject.emtreeCholesterol blood level
dc.subject.emtreeClinical article
dc.subject.emtreeCognition
dc.subject.emtreeControlled study
dc.subject.emtreeCorrelation analysis
dc.subject.emtreeDementia
dc.subject.emtreeDepth perception
dc.subject.emtreeDisease severity
dc.subject.emtreeFolic acid blood level
dc.subject.emtreeGlucose blood level
dc.subject.emtreeHemoglobin blood level
dc.subject.emtreeHuman
dc.subject.emtreeMemory
dc.subject.emtreeMini mental state examination
dc.subject.emtreeNeuropsychological test
dc.subject.emtreeParkinson disease
dc.subject.emtreeProtein blood level
dc.subject.emtreeThinking
dc.subject.emtreeThyrotropin blood level
dc.subject.emtreeVerbal memory
dc.subject.emtreeVisual memory
dc.subject.emtreeVitamin blood level
dc.subject.scopusParkinson's Disease; Cognition; Cognitive Dysfunction
dc.subject.wosClinical neurology
dc.titleEvaluation the cognitive functions in parkinson's disease patients with neuropsychometric tests and to identify its clinical correlates
dc.title.alternativeParkinson hastalarında kognitif fonksiyonların nöropsikometrik testlerle deǧerlendirilmesi ve parkinson hastalıǧı kliniǧi ile korelasyonu
dc.typeArticle
dc.wos.quartileN/A
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nöroloji Ana Bilim Dalı
local.indexed.atTrDizin
local.indexed.atWOS
local.indexed.atScopus

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Yıldız_vd_2010.pdf
Size:
131.63 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: